Ireland· IE-PA-EU/1//06/343/01

Baraclude

A entecavir product containing entecavir, registered in Ireland by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 17 of our 19 countries.

ATC J05AF10

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about entecavirAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Entecavir is registered in 17 of 19 countries.

Countries holding a registration under ATC J05AF10 (entecavir), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
10 of them publish a price we can compare per daily dose

Search entecavir products by name

Entecavir · ATC J05AF10

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of entecavir costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $0.20 in United States to $12.37 in Switzerland — a ×61 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Entecavir · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$12.37
FR France$7.50
IT Italy$4.93
US United States$0.20 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Entecavir
Manufacturer: Bristol-Myers Squibb Pharma EEIG
Country: Ireland (IE)
ATC code: J05AF10
ATC class: Entecavir
Defined daily dose: 0.5 mg, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
EU/1//06/343/01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for entecavir.

Graded by severity as the source publishes them — 56 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check entecavir against other medicines How interaction checks work

Entecavir · interactions on record

56 records

56 moderate

Most severe, free to view

CimetidineA02BA01moderate
RanitidineA02BA02moderate
FamotidineA02BA03moderate
NeomycinA07AA01moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Entecavir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All entecavir products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Entecavir Ratiopharm
Bulgaria · Ентекавир Pharmascience International Ltd, Ентекавир Зентива
Cyprus · Entevirem
Czechia · Entecavir Fmk, Entecavir Sandoz
Germany · Entecavir Al, Entecavir Amarox
Denmark · Edevira, Entecavir Medical Valley
Spain · Entecavir Aurovitas, Entecavir Dr. Reddys
Finland · Entecavir Stada
France · Entecavir Arrow, Entecavir Biogaran
United Kingdom (Northern Ireland) · Entecavir Accord-Uk, Entecavir Amarox
Greece · Edevira, Entecavir Sandoz
Hungary · Entecavir Pharmascience International Ltd, Entecavir Teva
Iceland · Baraclude, Entecavir Accord
Italy · Entecavir Aristo, Entecavir Aurobindo
Liechtenstein · Baraclude, Entecavir Accord
Lithuania · Entecavir Sandoz
Malta · Entecavir Dr. Reddy's, Entecavir Normon
Netherlands · Entecavir Amarox, Entecavir Aurobindo
Norway · Baraclude, Entecavir Accord
Poland · Entecavir Aurovitas, Entecavir Polpharma
Portugal · Entecavir Farmoz, Entecavir Generis
Romania · Entecavir Labormed, Entecavir Sandoz
Sweden · Entecavir Amarox, Entecavir Medical Valley
Slovenia · Entekavir Sandoz, Entekavir Stada
Slovakia · Entecavir Fmk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bc5a7ed1-4749-4c1b-b1fe-542544c66d5c
GET /v1/drugs/bc5a7ed1-4749-4c1b-b1fe-542544c66d5c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "J05AF",
    "J05AF10"
  ],
  "strength": null,
  "pa_number": "EU/1//06/343/01",
  "substances": [
    "Entecavir"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": null,
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about entecavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console